18-year veteran Saharsh will position the CDMO as a premier global API process development and commercial manufacturing specialist
Lonza will take on technology transfer, process optimization, and cGMP manufacturing, leveraging its global network and expertise in highly potent compounds
Broadens downstream purification portfolio with next-generation Protein A chromatography for scalable manufacturing
The company now offers the complete range of Apomorphine Hydrochloride in different fill volumes
The CDMO Leadership Awards spotlight top-performing development and manufacturing service providers
Sugammadex injection is bioequivalent to Merck’s Bridion injection for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults and pediatric patients aged 2 years and older undergoing surgery
The partnership has already launched with five active development programs, with both organizations jointly managing regulatory strategy and documentation under a structured, milestone-gated framework
The inspection is now closed, and no regulatory action has been recommended
The milestone moves the company closer to its previously announced $120 million US expansion, with groundbreaking slated for late 2026
Subscribe To Our Newsletter & Stay Updated
